what are the risks of glp 1 drugs Part 2 a 3-Part Series; GLP-1 Medications for Weight Loss Exploring the Side Effects of
Description
In the first 5 months of 2025, there were 1,392 prescriptions filled at the specialty pharmacy
GLP-1 drugs contain peptide molecules that cannot pass the skin barrier through the current transdermal patch technology
The identification of comorbidities was based on ICD-10-CM codes
( 10.2337/db08-1193) [DOI] [PMC free article] [PubMed] [Google Scholar] Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li RK, Volchuk A, Robinson LA, Billia F, Drucker DJ, et al
Given the expense of both the classes, therapy should be stopped in patients that fail to respond
D.DunseathG.LockettA.Broke-SmithT
